<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346886</article-id>
      <article-id pub-id-type="pmc">3875988</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132160</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Diffuse systemic sclerosis with bullous lesions without systemic
manifestations<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Esclerose sistemica difusa bolhosa sem acometimentos
sistemicos</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Macedo</surname>
            <given-names>Paula Renaux Wanderley Caratta</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mota</surname>
            <given-names>Amanda Nascimento Cavalleiro de Macedo</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gripp</surname>
            <given-names>Alexandre Carlos</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alves</surname>
            <given-names>Maria de Fatima Guimar&#xE3;es Scotelaro</given-names>
          </name>
          <xref ref-type="aff" rid="aff03">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Klumb</surname>
            <given-names>Evandro Mendes</given-names>
          </name>
          <xref ref-type="aff" rid="aff04">4</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Resident doctor in dermatology at the Pedro Ernesto University Hospital
- State University of Rio de Janeiro (HUPE-UERJ) - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff02"><label>2</label> Master's in dermatology from the Federal Fluminense University (UFF).
Assistant professor of dermatology at the State University of Rio de Janeiro (UERJ) -
Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff03"><label>3</label> PhD in dermatology from the Federal University of Rio de Janeiro
(UFRJ). Adjunct professor of dermatology at the State University of Rio de Janeiro
(UERJ) - Rio de Janeiro (RJ), Brazil.</aff>
      <aff id="aff04"><label>4</label> Master's in medical sciences - Adjunct professor of reumatology,
Faculty of Medical Sciences - State University of Rio de Janeiro (FCM-UERJ) -
Reumatologist of the Pedro Ernesto University Hospital - State University of Rio de
Janeiro (RJ), Brazil.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Paula Renaux Wanderley Caratta Macedo, Avenida 28 de
setembro, 77, 20551-080 - Vila Isabel, Rio de Janeiro - RJ, Brazil. Email:
<email>paula_renaux@yahoo.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>78</fpage>
      <lpage>81</lpage>
      <history>
        <date date-type="received">
          <day>26</day>
          <month>9</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>1</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Here, we describe an atypical case of systemic sclerosis in its diffuse cutaneous
form with acute and rapid progression of the cutaneous condition, without any
systemic manifestations and the infrequent formation of bullae, showing the
importance of diagnosis and early treatment in such cases. This case also shows that
special measures should be taken for bullous cutaneous lesions and ulcerations
resulting from serious sclerosis, which are entry points and increase morbidity and
risk of death. Other prognostic factors include age, ESR and renal and pulmonary
involvement. Capillaroscopies can be useful predictors of greater severity of
systemic scleroderma, revealing a greater link with systemic, rather than cutaneous,
involvement.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Descrevemos um caso at&#xED;pico de esclerose sist&#xEA;mica em sua forma cut&#xE2;nea difusa com
instala&#xE7;&#xE3;o aguda e r&#xE1;pida progress&#xE3;o do quadro cut&#xE2;neo sem qualquer acometimento
sist&#xEA;mico e a infrequente forma&#xE7;&#xE3;o de bolhas, demostrando a import&#xE2;ncia do
diagn&#xF3;stico e tratamento precoce frente a casos semelhantes e mostrando, com a
experi&#xEA;ncia deste caso, que cuidados especiais devem ser tomados com as les&#xF5;es
cut&#xE2;neas bolhosas e as ulcera&#xE7;&#xF5;es decorrentes da grave esclerose que s&#xE3;o portas de
entrada e aumentam a morbidade e risco de morte. Outros fatores progn&#xF3;sticos
descritos s&#xE3;o idade, VHS e envolvimento pulmonar e renal. A capilaroscopia pode ser
preditor de maior gravidade da esclerodermia sist&#xEA;mica, guardando maior rela&#xE7;&#xE3;o com o
envolvimento sist&#xEA;mico do que cut&#xE2;neo.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Connective tissue diseases</kwd>
        <kwd>Scleroderma, diffuse</kwd>
        <kwd>Scleroderma, systemic</kwd>
        <kwd>Skin diseases, vesiculobullous</kwd>
        <kwd>Skin and connective tissue diseases</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Systemic sclerosis, in its diffuse cutaneous form, is characterized by an initial
edematous phase, giving rise to cutaneous thickening of centrifugal evolution, often
without any vasospastic phenomena. This form of the disease typically spares the nipples
and manifests with diffuse hyperpigmentation, bearing a similar color to that found in
adrenal insufficiency. <sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref></sup> In most cases, it manifests with
esophageal, pulmonary, renal or cardiac, involvement. Almost no predilection by sex has
been noted.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Male, aged 61, presenting cutaneous sclerosis involving acute onset, progressive
evolution, of centrifugal character, for 3 months, associated with functional limitation
of joint movements and oral opening. The dermatological exam revealed hyperpigmentation
and diffuse cutaneous thickening, sparing the nipples, an increase in hand volume
without any vasospastic phenomena or sclerodactyly, and tense bullous lesions in the
lower limbs (<xref ref-type="fig" rid="f01">Figures 1</xref>,<xref ref-type="fig" rid="f02">2</xref> and <xref ref-type="fig" rid="f03">3</xref>). He did not present
comorbidity, was a smoker and social drinker, and worked as a general assistant. He
presented no exposure to chemical products like vinyl chloride, silica, etc. Additional
tests did not reveal abnormalities, except for elevated ESR and ANA 1:320 with fine
speckled cytoplasmatic pattern, negative results for rheumatoid factor,
anti-topoisomerase, anti-centromere and anti-RNP. Capillaroscopy of the nail bed with
hairpin-shaped capillary loops, without pathological megacapillaries, ramifications or
intersections, corresponding to discrete microcirculatory changes of nonspecific
character. The histopathological analysis showed an area of intense subepidermal edema,
forming multiocular bullae, moderate perivascular mononuclear infiltrate, collagen
compression, incarceration of annexes and lymphangiectasias (<xref ref-type="fig" rid="f04">Figures 4</xref> and <xref ref-type="fig" rid="f05">5</xref>). Colloidal
iron staining was weakly positive for mucin in the dermis. Given the rapid evolution of
the disease, treatment was started using cyclophosphamide 1g/kg/month and prednisone. In
outpatient follow-up, after 5 cycles, there was partial improvement in the cutaneous
sclerosis, without any specific organic involvement.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Hyperpigmentation and diffuse cutaneous thickening, sparing the nipples</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0078-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Increase in hand volume without thickening or sclerodactyly - characteristic of
diffuse cutaneous systemic sclerosis</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0078-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Tense bullous lesions and exculcerations, predominantly in the lower limbs</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0078-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Subepidermal edema forming multiocular bullae, collagen compression and
incarceration of annexes</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0078-g04"/>
      </fig>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Lymphangiectasia</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0078-g05"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Here, we describe an atypical case of systemic sclerosis in its diffuse form, an
exuberant, acute, serious cutaneous condition involving rapid progression, with
formation of bullae, an infrequent finding, without presenting any specific systemic
changes. It is not clear why the patient developed such a disproportion between the
cutaneous and systemic condition but we believe that the continuing preservation of
organs during the evolution of the patient can be explained by the early therapeutic
intervention. Initially, other diagnostic hypotheses were considered for the exceptional
nature of the case, like scleromyxedema, discarded following the histopathological
analysis and other scleroderma syndromes through occupational exposure (chemical agents
such as vinyl chloride, bleomycin, silica), discarded due to the lack of an
epidemiological context of exposure. </p>
      <p>The formation of bullae has been described in all types of scleroderma and it is a rare
finding. In this case, the bullae resulted from the subepidermal edema brought about by
lymphangiectasias, secondary to fibrosis and lymphatic obstruction.<sup><xref ref-type="bibr" rid="r03">3</xref>,<xref ref-type="bibr" rid="r04">4</xref></sup>
</p>
      <p>The ANA fine speckled cytoplasmic pattern found can be associated with the antibody
anti-histidyl t RNA synthetase (Jo-1), an antibody indicating polymyositis in adults and
rarely reported in dermatomyositis.<sup><xref ref-type="bibr" rid="r05">5</xref></sup>
However, due to a lack of clinical data reinforcing this association in the exam of the
patient in question, such as proximal muscle weakness, cutaneous lesions that are
typical or indicative of muscular lesions, we consider this hypothesis unlikely. In most
cases, the clinical relevance of the (recently reported) ANA cytoplasmic pattern is not
defined, and other anti-tRNA synthetase antibodies can generate the same pattern.
Drawing on the clinical situation described, the expected ANA pattern would be the
nucleolar speckled one, associated with the antibody anti-RNA polymerase I, which
corresponds to the diffuse form of systemic sclerosis. </p>
      <p>The mucin finding in this case should not lead us to regard the mucinosis as primary but
rather, as secondary to the exacerbated inflammatory process the patient developed, with
the stimulation of mucin production by the fibroblasts. It is an extremely rare finding
in scleroderma and is more common in systemic erythematosus lupus and
dermatomyositis.<sup><xref ref-type="bibr" rid="r06">6</xref>,<xref ref-type="bibr" rid="r07">7</xref></sup>
</p>
      <p>Treatment for cases of extensive cutaneous conditions that progress rapidly can be
carried out with cyclophosphamide, with or without another immunosuppressive agent,
including mycophenolate mofetil or azathioprine. Another treatment option is the
administering of rituximab.<sup><xref ref-type="bibr" rid="r08">8</xref></sup> After 5
cyclophosphamide pulses, the patient experienced partial improvement in the cutaneous
sclerosis, multiple hospitalizations due to infection, still without the specific
systemic manifestations of the disease, perhaps on account of the early and aggressive
treatment. </p>
      <p>Prognosis is linked to affected organs in cases of systemic disease and some
laboratorial markers. The presence of renal involvement (progressive loss of renal
function or proteinuria over 3.5g/day or cellular cylinders in urine), cardiac
involvement (cardiac insufficiency, pericarditis or electrocardiographic changes) and
pulmonary involvement (pleurisy, pulmonary hypertension, fibrosis or reduced diffusion
capacity), at the time of diagnosis, are indications of worse prognosis. Esophageal,
intestinal, muscular and joint involvement; the presence of the Raynald phenomenon;
hypertension; hypergammaglobulinemia (as shown in this case); and positive rheumatoid
factor, are not linked to bad prognosis. In males who are over 50 and experience an
increase in ESR, as in the case of the patient in question, it is associated with lower
survival rates.<sup><xref ref-type="bibr" rid="r09">9</xref></sup> A periungual
capillaroscopy showing the presence of devascularization can be a predictor of greater
severity of the systemic scleroderma, entailing a greater link with visceral (rather
than cutaneous) involvement<sup><xref ref-type="bibr" rid="r10">10</xref></sup> In the
case described, the capillaroscopy showed hairpin-shaped capillary loops, without any
signs of devascularization, reaffirming the fact that, to date, there has been no
systemic involvement.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <p>* Work carried out at the Pedro Ernesto University Hospital - State University of Rio
de Janeiro (HUPE-UERJ) - Rio de Janeiro (RJ), Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial funding: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Callen</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Jorizzo</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <source>Dermatological Signs of Internal Disease</source>
          <edition>2nd ed</edition>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>WB Saunders</publisher-name>
          <year>1995</year>
          <fpage>21</fpage>
          <lpage>30</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Sontheimer</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Provost</surname>
              <given-names>TT</given-names>
            </name>
          </person-group>
          <source>Cutaneous manifestations of rheumatic diseases</source>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
          <year>2003</year>
          <fpage>233</fpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tuffanelli</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Localized scleroderma</article-title>
          <source>Semin Cutan Med Surg</source>
          <year>1998</year>
          <volume>17</volume>
          <fpage>27</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">9512104</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rencic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Goyal</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Mofid</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Wigley</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Nousari</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>Bullous lesions in scleroderma</article-title>
          <source>Int J Dermatol</source>
          <year>2002</year>
          <volume>41</volume>
          <fpage>335</fpage>
          <lpage>339</lpage>
          <pub-id pub-id-type="pmid">12100687</pub-id>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dellavance</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>J&#xFA;nior</surname>
              <given-names>AG</given-names>
            </name>
            <name>
              <surname>Nuccitelli</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Taliberti</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>M&#xFC;hlen</surname>
              <given-names>CAv</given-names>
            </name>
            <name>
              <surname>Bichara</surname>
              <given-names>CDA</given-names>
            </name>
            <etal>et al</etal>
          </person-group>
          <article-title xml:lang="pt">3. Consenso Brasileiro para pesquisa de autoanticorpos
em c&#xE9;lulas HEp-2 (FAN). Recomenda&#xE7;&#xF5;es para padroniza&#xE7;&#xE3;o do ensaio de pesquisa de
autoanticorpos em c&#xE9;lulas HEp-2, controle de qualidade e associa&#xE7;&#xF5;es
cl&#xED;nicas</article-title>
          <source>Rev Bras Reumatol</source>
          <year>2009</year>
          <volume>49</volume>
          <fpage>89</fpage>
          <lpage>109</lpage>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rongioletti</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gambini</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Micalizzi</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pastorino</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Rebora</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Mucin deposits in Morphea and systemic Scleroderma</article-title>
          <source>Dermatology</source>
          <year>1994</year>
          <volume>189</volume>
          <fpage>157</fpage>
          <lpage>158</lpage>
          <pub-id pub-id-type="pmid">8075444</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Martin-Bracciani</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Cogrel</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Beylot-Barry</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ly</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Doutre</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Beylot</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Strip papular mucinosis associated with systemic
sclerosis</article-title>
          <source>Ann Dermatol Venereol</source>
          <year>2004</year>
          <volume>131</volume>
          <fpage>361</fpage>
          <lpage>364</lpage>
          <pub-id pub-id-type="pmid">15258510</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Manno</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Boin</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Immunotherapy of systemic sclerosis</article-title>
          <source>Immunotherapy</source>
          <year>2010</year>
          <volume>2</volume>
          <fpage>863</fpage>
          <lpage>878</lpage>
          <pub-id pub-id-type="pmid">21091117</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Braverman</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
          <source>Skin signs of systemic disease</source>
          <edition>3rd ed.</edition>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Saunders</publisher-name>
          <year>1998</year>
          <fpage>255</fpage>
          <lpage>377</lpage>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Skare</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Esmanhotto</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Casnoch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Silva</surname>
              <given-names>MB</given-names>
            </name>
          </person-group>
          <article-title>Nail fold capillaroscopy and systemic scleroderma
severity</article-title>
          <source>An Bras Dermatol</source>
          <year>2008</year>
          <volume>83</volume>
          <fpage>125</fpage>
          <lpage>127</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
